BBOTVSERAS• 12 Months (Normalized)
BBOT vs ERAS (BridgeBio Oncology Therapeutics Inc. vs Erasca Inc.)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-68.73%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
ERAS Performance $14.74
+592.02%
Erasca Inc.
Normalized Baseline0.00%
Alpha Spread Margin ERAS LEADS
-660.75 pts
ERAS outperforming by 660.75 percentage points
BBOTERAS
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT ERAS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | BBOT Price | BBOT Gain (%) | ERAS Price | ERAS Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -68.73% | $14.74 | +592.02% | -660.75% |
| Sep 30, 2026 | $4.10 | -67.04% | $- | - | |
| Sep 29, 2026 | $3.92 | -68.49% | $- | - | |
| Sep 28, 2026 | $3.81 | -69.37% | $14.13 | +563.38% | -632.75% |
| Sep 25, 2026 | $3.95 | -68.25% | $14.25 | +569.01% | -637.26% |
| Sep 24, 2026 | $3.99 | -67.93% | $14.52 | +581.69% | -649.62% |
| Sep 23, 2026 | $4.16 | -66.56% | $13.95 | +554.69% | -621.25% |
| Sep 22, 2026 | $4.66 | -62.54% | $15.55 | +630.05% | -692.59% |
| Sep 21, 2026 | $4.66 | -62.54% | $15.04 | +606.10% | -668.64% |
| Sep 18, 2026 | $4.77 | -61.66% | $14.77 | +593.43% | -655.09% |
| Sep 17, 2026 | $4.89 | -60.69% | $15.34 | +620.19% | -680.88% |
| Sep 16, 2026 | $4.76 | -61.74% | $15.36 | +621.13% | -682.87% |
| Sep 15, 2026 | $4.88 | -60.77% | $16.25 | +662.91% | -723.68% |
| Sep 14, 2026 | $5.05 | -59.41% | $16.16 | +658.69% | -718.10% |
| Sep 11, 2026 | $4.95 | -60.21% | $15.88 | +645.54% | -705.75% |
Page 1 of 17